Renalytix Plc
RTNXF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,728 | -$7,074 | -$7,743 | -$8,485 |
| Dep. & Amort. | $60 | $60 | $69 | $108 |
| Deferred Tax | $0 | -$145 | $0 | -$1,247 |
| Stock-Based Comp. | $254 | $419 | $671 | $97 |
| Change in WC | -$86 | -$2,831 | $734 | -$12 |
| Other Non-Cash | $664 | $1,600 | -$919 | $1,620 |
| Operating Cash Flow | -$3,836 | -$7,826 | -$4,862 | -$7,919 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1 | -$3 | $0 |
| Net Acquisitions | $23 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $23 | -$1 | -$3 | -$5 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$600 |
| Stock Issued | $0 | $8,461 | $5,072 | $93 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$672 | -$1,039 | $0 |
| Financing Cash Flow | $0 | $7,789 | $4,033 | -$507 |
| Forex Effect | $42 | $14 | -$88 | $159 |
| Net Chg. in Cash | -$3,771 | -$24 | -$915 | -$8,272 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,680 | $4,704 | $5,619 | $13,891 |
| End Cash | $909 | $4,680 | $4,704 | $5,619 |
| Free Cash Flow | -$3,836 | -$7,827 | -$4,865 | -$7,919 |